gsgs
Registered User
http://www.ncbi.nlm.nih.gov/pubmed/22423139
We randomized 115 children to trivalent inactivated influenza vaccine (TIV) or placebo.
Over the following 9 months, TIV recipients had increased risk of virologically-confirmed
non-influenza infections (relative risk: 4.40; 95% confidence interval: 1.31-14.8).
Being protected against influenza, TIV recipients may lack temporary non-specific
immunity that protected against other respiratory viruses.
We randomized 115 children to trivalent inactivated influenza vaccine (TIV) or placebo.
Over the following 9 months, TIV recipients had increased risk of virologically-confirmed
non-influenza infections (relative risk: 4.40; 95% confidence interval: 1.31-14.8).
Being protected against influenza, TIV recipients may lack temporary non-specific
immunity that protected against other respiratory viruses.
Last edited by a moderator: